Cargando…

Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease

We aimed to examine whether miRNA-29s (miR-29s) in serum are associated with cognitive impairment in Parkinson’s disease (PD). Thirty-nine PD patients with normal cognition (PD-NC), 37 PD patients with mild cognitive impairment (PD-MCI), 22 PD patients with dementia (PDD) and 40 healthy controls wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Linlin, Tang, Yilin, Bai, Xiaochen, Liang, Xiaoniu, Fan, Yun, Shen, Yan, Huang, Fang, Wang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377865/ https://www.ncbi.nlm.nih.gov/pubmed/32649312 http://dx.doi.org/10.18632/aging.103458

Ejemplares similares

Downregulation of blood serum microRNA 29 family in patients with Parkinson’s disease
por: Bai, Xiaochen, et al.
Publicado: (2017)

Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia
por: Tang, Yilin, et al.
Publicado: (2023)

Determinants of Quality of Life According to Cognitive Status in Parkinson’s Disease
por: Fan, Yun, et al.
Publicado: (2020)

Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease
por: Tang, Yilin, et al.
Publicado: (2020)

The microRNA-29 family in cartilage homeostasis and osteoarthritis
por: Le, Linh T. T., et al.
Publicado: (2015)

Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson’s Disease
por: Han, Linlin, et al.
Publicado: (2021)

Heath management app use in Parkinson’s disease and quality of life during the COVID-19 pandemic
por: Tang, Yilin, et al.
Publicado: (2023)

Regulatory microRNAs and vascular cognitive impairment and dementia
por: Zhang, Jing, et al.
Publicado: (2020)

Determinants of quality of life in Parkinson’s disease: a perspective of novel clinical subtypes
por: Fan, Yun, et al.
Publicado: (2021)

CSF MicroRNAs Reveal Impairment of Angiogenesis and Autophagy in Parkinson Disease
por: Fowler, Alan J., et al.
Publicado: (2021)

Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson’s Disease
por: Tang, Yilin, et al.
Publicado: (2016)

Profiling circulating microRNAs in maternal serum and plasma
por: GE, QINYU, et al.
Publicado: (2015)

Plasma microRNA biomarkers for detection of mild cognitive impairment
por: Sheinerman, Kira S., et al.
Publicado: (2012)

MicroRNAs Related to Cognitive Impairment After Hearing Loss
por: Mun, Seog-Kyun, et al.
Publicado: (2021)

The microRNA-29 Family Dictates the Balance Between Homeostatic and Pathological Glucose Handling in Diabetes and Obesity
por: Dooley, James, et al.
Publicado: (2016)

Age-dependent increase of oxidative stress regulates microRNA-29 family preserving cardiac health
por: Heid, Johanna, et al.
Publicado: (2017)

MicroRNA 29 Family Serves a Key Role in Lung Development and the Prevention of Lung Pathology
por: Mishra, Ritu, et al.
Publicado: (2021)

Prediction of Quality of Life in Patients With Parkinson’s Disease With and Without Excessive Daytime Sleepiness: A Longitudinal Study
por: Zhang, Lixia, et al.
Publicado: (2022)

Pathophysiological role of microRNA-29 in pancreatic cancer stroma
por: Kwon, Jason J., et al.
Publicado: (2015)

Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
por: Wu, Yun, et al.
Publicado: (2013)

MicroRNA 29a therapy for CEACAM6-expressing lung adenocarcinoma
por: Son, Seung-Myoung, et al.
Publicado: (2023)

Effect of microRNA-29b on proliferation, migration, and invasion of endometrial cancer cells
por: Kong, Jian, et al.
Publicado: (2019)

MicroRNA-Based Diagnosis and Therapeutics for Vascular Cognitive Impairment and Dementia
por: Zhai, Weijie, et al.
Publicado: (2022)

Downregulation of microRNA-29c reduces pain after child delivery by activating the oxytocin-GABA pathway
por: Li, Caijuan, et al.
Publicado: (2020)

Role of MicroRNAs in Parkinson’s Disease
por: Goh, Suh Yee, et al.
Publicado: (2019)

Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients
por: Jiang, Yanyan, et al.
Publicado: (2021)

Integrated analyses of microRNA-29 family and the related combination biomarkers demonstrate their widespread influence on risk, recurrence, metastasis and survival outcome in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2019)

Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease
por: Sun, Shujun, et al.
Publicado: (2022)

Exosomal MicroRNAs Contribute to Cognitive Impairment in Hypertensive Patients by Decreasing Frontal Cerebrovascular Reactivity
por: Ma, Junyi, et al.
Publicado: (2021)

Quality of life: Seasonal fluctuation in Parkinson's disease
por: Wu, Lei, et al.
Publicado: (2023)

Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats
por: Silveira, André C., et al.
Publicado: (2017)

The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond
por: Lin, Hung-Yu, et al.
Publicado: (2020)

Deficiency of miR-29a/b1 leads to premature aging and dopaminergic neuroprotection in mice
por: Bai, Xiaochen, et al.
Publicado: (2022)

MicroRNA-29c affects zebrafish cardiac development via targeting Wnt4
por: Shen, Yahui, et al.
Publicado: (2020)

Parkinson's Disease and Cognitive Impairment
por: Yang, Yang, et al.
Publicado: (2016)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment
por: Weinberg, Rebecca B., et al.
Publicado: (2015)

MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer’s Disease
por: De Felice, Bruna, et al.
Publicado: (2020)

Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
por: Ogonowski, Natalia, et al.
Publicado: (2022)

Anxiety and depression symptoms among caregivers of care-recipients with subjective cognitive decline and cognitive impairment
por: Liang, Xiaoniu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vjtas46j42lq2jmo41tjnqmmj4